Connect with us

Tech Interviews

How Aspen Medical is Leveraging AI to Deliver Healthcare in Crisis Zones and Remote Regions

Published

on

How Aspen Medical is Leveraging AI to Deliver Healthcare in Crisis Zones and Remote Regions

Exclusive Interview with Glenn Keys, Founder and Executive Chair, Aspen Medical

A portrait of Glenn Keys, Founder and Executive Chair, Aspen Medical
Glenn Keys, Founder and Executive Chair, Aspen Medical

Aspen Medical has a strong legacy in humanitarian and military healthcare. How does AI fit into your long-term vision for transforming healthcare delivery, particularly in the UAE and MEA region?

Everything we do at Aspen Medical is health-led and technology-enabled. Our existing systems, governance, training and so on, are about the delivery of high-quality and safe care wherever our clients need us. Technology, including artificial intelligence (AI) enables us to do this. At Aspen Medical, we see AI as an integral part of our strategy to reimagine healthcare access and delivery. In the UAE and broader MEA region, rapid development is creating new demands for precision, resilience and scalability in health systems. AI will enable us to meet those demands in ways that are faster and smarter, for example, embedding AI into remote diagnostics, predictive modelling and digital triage, especially in primary and emergency care settings. In the UAE, where digital transformation is a national priority, we’re aligning with initiatives like the National Strategy for Artificial Intelligence 2031. AI strengthens our capacity to deliver care that is accessible, responsive and tailored to diverse populations.

In humanitarian zones where traditional infrastructure is limited or absent, how can AI-powered healthcare solutions help close the gap in access, diagnostics, and continuity of care?

In regions facing instability, displacement or lacking basic infrastructure, AI can help overcome barriers that have long blocked access to care. Using AI-enabled triage tools, speech recognition and machine translation, language and literacy barriers are reduced whilst guiding patients toward appropriate care pathways. AI technologies that support health workers on the ground – scanning images, analysing vitals and supporting early intervention – can be embedded into mobile devices allowing deployable clinical teams to operate in even the most remote or disconnected settings. Combined with cloud-based health records, AI can ensure continuity of care across humanitarian corridors. It’s not going to be about replacing clinicians; it will be about improving outcomes where they are needed most.

Deployable healthcare is a core pillar of Aspen Medical’s work. How is AI being used to prepare healthcare professionals for unpredictable, high-stress environments such as disaster zones or military operations – and what outcomes have you seen so far?

When lives are on the line, preparation is everything. That’s why we’re working towards integrating AI into the way we train and prepare our deployable healthcare teams. Our goal is to enable clinicians and responders to experience realistic, high-stress environments ranging from natural disasters to military deployments before they ever set foot in the field. By developing AI-powered virtual reality and adaptive learning platforms, we aim to replicate mass casualty incidents, austere conditions, and trauma scenarios. This technology will allow us to track decision-making under pressure and tailor learning in real time. We’re striving to build systems that enhance response times, improve triage accuracy, and boost confidence in the field. Ultimately, we’re working towards using AI not only to strengthen operational readiness but also to reduce burnout and build psychological resilience before deployment.

What role does AI play in enhancing the efficiency and responsiveness of mobile clinics and field hospitals? How is Aspen Medical applying these technologies to support remote workforce health in sectors like oil & gas and humanitarian aid?

AI is beginning to play a supportive role across our mobile clinics and field hospitals, helping teams make better, faster decisions in complex environments. At Aspen Medical, we’re exploring how AI can assist with triage, inventory management, logistics, and reporting, always with clinicians and field experts in control. Early algorithms are helping us analyse trends in patient data and resource use, offering insights that complement, not replace, human judgement. In sectors such as oil and gas, AI tools are being trialed to identify emerging health patterns, like fatigue or heat stress, by combining wearable and clinical data under the supervision of our medical staff. In humanitarian and disaster response settings, these systems are helping improve coordination and data continuity as populations move across regions. Our focus is on using AI responsibly to enhance situational awareness and operational resilience, keeping humans at the centre of every decision that affects care.

Is Aspen Medical collaborating with governments or local health authorities to scale AI-driven solutions across the region as well as globally? What have been the most promising outcomes or lessons from these partnerships?

Yes, we are working directly with health ministries, defence forces and regulators across the UAE and other MEA countries to localise AI solutions that meet national goals. These partnerships are built on co-design: we bring our clinical expertise and global experience, and local authorities bring contextual insight and public health priorities. The most promising outcomes stem from long-term trust. When local systems are involved from the start, adoption increases and impact is sustained.

What would you say are the biggest barriers to AI adoption in healthcare today, and how can companies like Aspen Medical ensure these technologies are deployed ethically and equitably across diverse communities?

Ethical deployment is the challenge and the opportunity. AI is only as effective as the data behind it, and in healthcare, bias or poor-quality data can be dangerous – it is vital that there are strict protocols to validate every AI tool. We prioritise transparency, clinical oversight and community input. We also advocate for inclusive AI, built with diverse datasets that reflect different genders, ethnicities and disease profiles.

Looking ahead, which emerging AI technologies do you believe have the greatest potential to revolutionize healthcare? How do you see Aspen Medical’s role evolving as AI becomes more integrated into healthcare infrastructure?

We believe technologies like generative AI, clinical large language models and AI-assisted imaging will drive the next wave of transformation. Imagine a frontline clinician dictating hands-free notes, while a real-time AI scribe prepares documentation and decision-support summaries. Or an emergency responder receiving instant feedback from an AI model scanning a wound image. Our goal is to leverage federated learning so AI systems can learn from decentralised, privacy-protected data sets. This approach will be critical for delivering safe, compliant, and coordinated care across borders. Our role is to be the connector: bringing together best-in-class technology, robust clinical practice and local insight to deliver safe, smart and scalable healthcare.

Finally, as a founder, what drives your commitment to innovation in healthcare? What legacy do you hope Aspen Medical leaves in the AI healthcare space, especially in regions facing complex and urgent challenges?

Innovation is in Aspen Medical’s DNA. We started by asking: How do we deliver high-quality care where others can’t or won’t go? Today, AI gives us powerful new ways to answer that question. Vitaport, our flagship workplace health and wellbeing platform, developed by Aspen Medical, is the embodiment of that vision. Using agentic AI grounded in clinical governance to deliver personalised care, real-time insights and behaviour-shaping support. But whilst our tools evolve, our purpose remains the same: people are always at the centre. I’m driven by the belief that healthcare must be a force for equity. AI is a tool, not a destination – it helps us extend our reach, deepen our impact, and build systems that are smarter, fairer and more human. The legacy I hope we leave is simple: that we used technology not just to innovate, but to uplift. Especially where the stakes are highest.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Tech Interviews

The Next Horizon: Manish Bakshi on BenQ’s Vision for a Human-Centric Digital Decade

Published

on

An exclusive conversation on AI ecosystems, smart learning and how modern leadership paradigms are redefining agility and long-term business resilience

As he marks nearly 25 years with BenQ Middle East, Managing Director Manish Bakshi looks firmly ahead, sharing his vision for the next decade of AI-powered ecosystems, smart learning, hybrid collaboration, esports and immersive home entertainment. In this exclusive Q&A, he discusses how BenQ is preparing to lead the next phase of digital transformation in the region.

After nearly 25 years of building BenQ in the region, what excites you most about the next decade?

Manish Bakshi: What excites me most is that we are moving beyond individual devices into connected, intelligent ecosystems. The next decade will not simply be about better hardware; it will be about how technology works together seamlessly to make experiences more intuitive, productive and human-centric.

At BenQ, we see the future being shaped by AI-powered ecosystems across education, enterprise and consumer technology. Whether it’s smart classrooms, intelligent meeting spaces or immersive home entertainment, our focus is on enabling technology that feels almost invisible, powerful, but effortless to use.

The Middle East is a particularly exciting region for this evolution because of the pace of digital transformation and the ambition we see across sectors.

You often speak about moving from products to ecosystems. What does that mean in practical terms?

Manish Bakshi: Traditionally, technology companies focused on standalone products. Today, the real opportunity lies in ecosystems, where displays, software, collaboration tools, cloud services and AI work in harmony.

For us, innovation is increasingly about creating connected solutions rather than isolated devices. In a meeting room, for example, the display, conferencing tools, wireless presentation systems and collaboration software should operate as one seamless environment.

AI will take this further by making those ecosystems adaptive, learning user preferences, simplifying workflows and enabling smarter decision-making.

That is where we see the future of technology heading.

Education is evolving rapidly. How do you see smart classrooms developing over the next five to ten years?

Manish Bakshi: We believe classrooms will become far more intelligent and personalised. The future is not just digital whiteboards replacing traditional ones, it’s AI-enabled learning environments where technology adapts to students’ needs in real time, provides teachers with actionable insights and makes learning more interactive and inclusive.

In the Middle East, governments and institutions are investing heavily in education transformation, and we see strong momentum around smart learning.

BenQ intends to play a leading role in this space by developing solutions that combine interactive displays, software ecosystems and well-being-focused innovation, including technologies designed around eye care and healthier learning environments.

The goal is simple: technology should support better learning outcomes, not add complexity.

Hybrid work has matured significantly. What’s the next chapter for workplace innovation?

Manish Bakshi: The first phase of hybrid work was about enabling remote participation. The next phase is about optimising the experience.

The future workplace will be frictionless. You walk into a meeting room, your device connects instantly, the room recognises your preferences, collaboration starts without delays, everything just works. We’re focused on intelligent meeting ecosystems that make collaboration natural regardless of location.

Another major focus will be human-centric workplace design, ergonomic displays, wellness-driven technologies and environments designed for long-term productivity and comfort.

The future office is not only smarter; it has to be healthier.

AI is driving much of today’s innovation conversation. How do you see AI transforming BenQ’s categories?

Manish Bakshi: AI will become the intelligence layer across everything we do. In education, it will personalise learning. In an enterprise, it will streamline collaboration and improve productivity. In consumer technology, it will create richer, more intuitive experiences.

But importantly, we see AI as an enabler, not a replacement for people. The role of AI is to remove friction, simplify complexity and empower users. That human-centric approach is very important to us.

Esports and gaming have become major growth sectors in the region. How do you view this opportunity?

Manish Bakshi: Esports is no longer niche; it is a mainstream ecosystem with economic, cultural and technological significance. The Middle East has made remarkable investments in gaming infrastructure, tournaments and talent development, and we see enormous long-term potential.

Our vision is not only to support professional esports through high-performance gaming innovation, but also to contribute to the growth of grassroots gaming communities in the region. This sector represents the convergence of technology, youth culture and digital creativity, and it will continue to expand.

BenQ has also been expanding into home entertainment. What trends do you see shaping that space?

Manish Bakshi: The home is being reimagined as an immersive entertainment space. Particularly in the GCC, where home experiences and family gatherings are such an important part of culture, we are seeing strong interest in cinematic home technologies. Laser TVs and ultra-short-throw projectors are transforming how people think about entertainment at home.

We see significant growth in this category over the coming years and plan to continue expanding solutions designed for the unique lifestyle and architectural preferences of the region.

This is one of the most exciting consumer opportunities ahead.

How do you see BenQ Middle East contributing to the region’s wider digital transformation agenda?

Manish Bakshi: Our role is to be more than a technology provider; we want to be a transformation partner. Across education, corporate and consumer segments, our focus is on supporting the region’s ambitions through innovation that aligns with future needs. That includes smarter ecosystems, sustainability-driven design, AI-enabled solutions and technologies that improve both productivity and well-being.

The Middle East is not just adopting innovation; in many areas, it is helping define it. We want to be part of shaping that future.

What leadership principle will guide you into this next decade?

Manish Bakshi: One principle remains constant: technology must serve people. No matter how advanced innovation becomes, the human element stays central. Leadership today is increasingly about orchestration, bringing together people, ideas and technology to create value collectively.

The next decade will belong to organisations that combine intelligence with purpose. For us at BenQ, the future is not simply about building smarter technologies. It is about enabling smarter, more meaningful experiences. And that is the vision driving our next chapter.

Continue Reading

Tech Interviews

ARCERA Accelerates Life Sciences Growth in Middle East

Published

on

Exclusive interview with Sunil Bhilotra, Chief Investment Officer, Arcera

Why is life sciences emerging as a priority asset class in the Middle East?

Life sciences is becoming a priority asset class because it sits at the intersection of healthcare resilience, industrial development and long-term economic value creation. Across the Middle East, governments are looking beyond healthcare delivery alone and asking how they can build deeper capability in clinical research and development, and manufacturing of innovative medicines. That shift is being driven by rising prevalence of acute and chronic diseases, greater focus on medicine security, and the need to reduce exposure to global supply disruptions.

From an investment perspective, the sector has attractive fundamentals. Demand is structural, the region’s population needs are evolving, and governments are creating the policy conditions for long-term growth. The UAE’s focus on genomics, pharmaceutical manufacturing and innovation is one example of how life sciences is becoming part of the wider economic diversification agenda.

Arcera was established within this context. By bringing a number of life sciences companies including Acino, M8 Pharmaceuticals and Amoun Pharmaceutical Company together under one company headquartered in Abu Dhabi, we have formed an integrated platform that employs more than 6,000 people across 90 markets, with a META footprint spanning 13 countries and more than 500 commercial colleagues on the ground. This reflects a broader regional shift toward building globally competitive life sciences platforms that combine strategic healthcare priorities with sustainable growth.

How is Arcera’s investment strategy driving resilience and long-term returns?

Our investment strategy is focused on building the conditions for durable long-term growth: scale, control, and relevance. By bringing complementary businesses together under one Abu Dhabi-headquartered platform, Arcera has created a stronger base from which to manage supply continuity, expand market reach, and invest with a longer horizon than a standalone pharmaceutical company could typically support.

That resilience is also what strengthens the return profile. We are not relying on one product, one market, or one growth lever. Our strategy combines an established portfolio with targeted investment in priority therapeutic areas, manufacturing capability, partnerships, M&A, and in-licensing. This gives the business a balanced model that enables stable revenue today, with room to capture future growth in areas where regional demand and global innovation are moving quickly.

Healthcare demand is structural, but returns depend on execution, access, and the ability to operate reliably across business and economic cycles. At Arcera, our strategy is designed around those fundamentals. It builds a platform that can absorb disruption, support national healthcare resilience, and create long-term value by connecting Abu Dhabi’s patient capital with real operating capability across the life sciences sector.

What role do M&A and in-licensing play in scaling across key therapeutic areas?

M&A is what built our foundation. When we brought together the businesses we acquired, we built a unique life sciences business with global regulatory, commercial, market access, supply chain and manufacturing capabilities that would take decades to build from scratch. That kind of scale gave us the operational base to run a leading global business structured in deeply rooted regional relevance, with the credibility to attract global partnerships.

But scale is not enough on its own. The portfolio has to evolve, and that is where in-licensing becomes critical. As an example, our licensing agreement with AriBio for an investigational oral Alzheimer’s therapy was a deliberate move into a disease area where the regional need is significant and the science is genuinely exciting. Another example is the collaboration agreement we signed with Fosun Pharma recently that takes that a step further, exploring licensing opportunities across oncology, neuroscience, rare diseases, and cardiometabolic health, and potentially localising advanced biotechnology in the UAE. These activities demonstrate how we are building scientific know-how on top of the commercial platform we already have.

Ultimately, M&A gives you the platform, and in-licensing gives you the future. Global innovators are looking for partners who can actually deliver their therapies to patients in complex markets. If you demonstrate track record and have the capabilities and experienced commercial teams on the ground, you become a genuinely attractive partner of choice for biotechs and multinationals. That is the position Arcera is building toward, and deals like the ones we are doing now are how you get there.

What makes Abu Dhabi a strong hub for patient capital and healthcare investment?

Abu Dhabi is a unique place where sovereign and commercial ambitions are highly aligned. Guided by the Department of Health – Abu Dhabi’s vision for preventative and personalised care at scale, as well as the Abu Dhabi Industrial Strategy’s ambition to position the Emirate as a leading industrial hub, the government has made healthcare and life sciences a strategic priority. This has enabled faster policy decisions, investment in infrastructure, and regulatory reform, creating a highly supportive foundation for long-term sector growth.

The ecosystem being built around sovereign capital is also maturing quickly. Organisations across the ecosystem are deeply engaged in developing healthcare and life sciences in the UAE and are playing active roles in driving its growth. At Make it in the Emirates for example, Arcera is announcing a number of collaborations that reflect the depth of collaboration taking shape across healthcare, manufacturing, and innovation. These are practical examples of how Abu Dhabi is creating the conditions for businesses to build, expand, and create long-term value within a supportive national framework.

What ultimately makes Abu Dhabi unique is that it is not trying to necessarily replicate what exists elsewhere, it is building its own model where sovereign capital, clinical capability, manufacturing infrastructure, and global partnerships come together in one place. For investors and companies like Arcera, this creates an environment where capital can be deployed with long-term confidence, while actively contributing to the development of a globally competitive life sciences ecosystem.

What does it take to build a globally competitive life sciences platform from the Gulf?

I believe it takes three things: scale, reputation and execution. Scale gives a company the footprint to compete internationally. Reputation comes from maintaining a high bar on quality systems, regulatory discipline, manufacturing standards and trusted partnerships. Execution is what connects those capabilities to patients.

For a UAE-based company, the opportunity is to combine regional proximity with global capability. Arcera is doing this by building from Abu Dhabi while operating across international markets, strengthening in key therapeutic focus areas such as cardiometabolism, neurosciences, oncology and rare disease, and investing in digital, data and AI to improve how we operate. The region has ambition, but ambition has to be matched by the patient, detailed work of integration, governance, quality and access.

What are your plans for the next few years?

We are in our second year as a fully integrated company, and we are committed to scaling our enterprise and deepen our commitment to bringing innovation, both in our day-to-day operations as well as in our portfolio of medicines. We will keep elevating our performance and expanding our long-term partnerships to strengthen global impact, while remaining steadfast in our support of Abu Dhabi and the UAE’s ambition to build a global life sciences and healthcare hub.

Our recent collaborations also open significant new possibilities, from licensing assets in advanced clinical development to potentially incubating new biotechnology capabilities on the ground in the UAE. Alongside that, we are deepening our digital and AI capabilities to drive greater speed and precision across everything from manufacturing to medical engagement.

Above all, we remain close to the needs of the patients and stakeholders who place their trust in us and remain focused on building for the next generations. The foundation is in place. The next phase is about translating it into lasting impact for patients and sustained value for our stakeholders.

Continue Reading

Tech Interviews

How AI Is Turning Network Cameras Into Real-Time Intelligence

Published

on

Exclusive interview with Bashar Al Daoud – Territory Sales Manager UAE & Oman, Axis Communications

1. How is AI transforming network cameras into real-time intelligence tools?

AI is moving cameras from just recording events to actually understanding what’s happening in real time. Instead of reviewing footage after the fact, the camera can now detect, classify, and trigger actions instantly — whether it’s identifying a person, detecting unusual behaviour, or flagging a safety risk. So the system becomes proactive, not reactive, and that’s a big shift in how organisations use video.

2. What role does edge AI play in reducing reliance on the cloud?

Edge AI means the intelligence sits inside the camera itself, not in the cloud. This reduces latency, lowers bandwidth usage, and allows decisions to be made immediately. It also strengthens data privacy, since sensitive information can stay on-site. The cloud still has a role, but edge processing is what really makes large-scale deployments more efficient and practical.

3. How are AI-powered cameras helping businesses cut costs and improve efficiency?

They reduce the need for constant manual monitoring — the system only alerts you when something actually matters.

They also help prevent incidents early, which can reduce losses and disruptions. And beyond security, they improve operations — things like queue management, traffic flow, or site efficiency. So it’s both cost-saving and performance improvement at the same time.

4. How does AI help future-proof network camera investments?

With AI-enabled cameras, especially on an open platform, you can add new applications over time without replacing the hardware. So today it’s security, tomorrow it could be analytics or operational insights. That flexibility is what future-proofs the investment — the system grows with the business instead of becoming outdated.

5. How is AI expanding network cameras beyond security into business intelligence?

We’re seeing cameras becoming data sources, not just security devices. They can provide insights on people movement, occupancy, and behaviour patterns, which helps organisations make better decisions. At ISNR Abu Dhabi, this is a big part of the conversation — how to use video data not just for protection, but to improve overall operations and planning.

6. How is Axis upscaling its game with AI security surveillance?

At Axis, we’ve been investing in AI at the edge for years, especially through our own chip technology. Our focus is on making sure the AI is reliable and works in real-world conditions, not just in theory. We also prioritise cybersecurity and open integration, so customers can build complete solutions with partners — not just standalone systems.

7. What are your plans for the next three years to up AI into your products?

The focus is on making AI more accurate, scalable, and easier to deploy. We’ll continue pushing more advanced analytics to the edge, while improving how video, audio, and other systems work together. At the same time, there’s a strong focus on responsible use — making sure AI is secure, transparent, and trusted by customers.

Continue Reading

Trending

Copyright © 2023 | The Integrator